Phase II trial of the effects of Pill-Plus triple-hormone oral contraceptive vs oral contraceptives alone on the sexual arousability and vascular component of sexual arousal response in women

Trial Profile

Phase II trial of the effects of Pill-Plus triple-hormone oral contraceptive vs oral contraceptives alone on the sexual arousability and vascular component of sexual arousal response in women

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2010

At a glance

  • Drugs Drospirenone/estradiol/prasterone (Primary) ; Estradiol/drospirenone
  • Indications Female sexual dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2010 Positive clinical results announced in a BioSante Pharmaceuticals media release. Additional data will be reported upon full publication of the study results.
    • 30 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top